“The High Resolution MASS spectrometry in Personalised Medicine: Retinol-Binding Protein 4 as a Candidate Biomarker Predictor of Progression in Bladder Urothelial Carcinoma” (2024) Acta Urológica Portuguesa, 38(1-2), pp. 12–17. doi:10.24915/aup.156.